We are live on ! Find out more
REVBW icon

Revelation Biosciences Warrant
REVBW

18 hedge funds and large institutions have $389K invested in Revelation Biosciences Warrant in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

10% less funds holding

Funds holding: 20 → 18 (-2)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

84% less capital invested

Capital invested by funds: $2.4M → $389K (-$2.01M)

Holders
18
Holders Change
-2
Holders Change %
-10%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
4
Closed
5
Calls
$56K
Puts
–
Net Calls
+$56K
Net Calls Change
-$454K

Top Buyers

Rank Fund Capital Flow
1
Walleye Capital
Walleye Capital
New York
+$23.1K
2
WAM
Wolverine Asset Management
Illinois
+$16.9K
3
TI
Telemetry Investments
New York
+$15.9K
4
Walleye Trading
Walleye Trading
New York
+$15.4K
5
LA
Linden Advisors
New York
+$14.5K

Top Sellers

Rank Fund Capital Flow
1
CH
CVI Holdings
Delaware
-$200K
2
ICM
Ionic Capital Management
New York
-$170K
3
RCM
Rivernorth Capital Management
Florida
-$136K
4
ICMH
Integrity Capital Management (HK)
Hong Kong
-$34K
5
Ameriprise
Ameriprise
Minnesota
-$16K
Name Holding Trade Value Shares
Change 		Change in
Stake
OCAM
1
Owl Creek Asset Management
New York
$128K – – –
LA
2
Linden Advisors
New York
$86K +$14.5K +56,926 +9%
YCM
3
Yakira Capital Management
Connecticut
$32K -$5.11K -20,001 -7%
EAM
4
Empery Asset Management
New York
$30K -$4.24K -16,618 -7%
TI
5
Telemetry Investments
New York
$19K +$15.9K +62,319 +77%
Walleye Capital
6
Walleye Capital
New York
$14K +$23.1K +90,478 +534%
Capstone Investment Advisors
7
Capstone Investment Advisors
New York
$12K – – –
PAMP
8
Polar Asset Management Partners
Ontario, Canada
$12K – – –
AC
9
Ayrton Capital
Connecticut
$10K – – –
Jane Street
10
Jane Street
New York
$10K +$5.27K +20,620 +37%
Walleye Trading
11
Walleye Trading
New York
$8K +$15.4K +60,224 New
WAM
12
Wolverine Asset Management
Illinois
$8K +$16.9K +66,273 New
PFM
13
Privium Fund Management
Netherlands
$6K – – –
HF
14
HRT Financial
New York
$4K – – –
VF
15
Virtu Financial
New York
$4K +$7.64K +29,935 New
EPM
16
Equitec Proprietary Markets
Illinois
$3K -$12.8K -50,000 -71%
SM
17
Skaana Management
New York
$2K – – –
UBS Group
18
UBS Group
Switzerland
$1K -$108 -421 -6%
CH
19
CVI Holdings
Delaware
– -$200K -294,500 Closed
ICM
20
Ionic Capital Management
New York
– -$170K -249,900 Closed
RCM
21
Rivernorth Capital Management
Florida
– -$136K -200,000 Closed
ICMH
22
Integrity Capital Management (HK)
Hong Kong
– -$34K -50,000 Closed
Ameriprise
23
Ameriprise
Minnesota
– -$16K -22,886 Closed

REVBW Hedge Fund Activity: Q1 2022 in Review

18 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q1 2022, worth a combined $389K — down 84% from $2.4M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of REVBW and 3 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 4 added.

The largest buyer was Walleye Capital, adding an estimated $23.1K. The largest seller was CVI Holdings, exiting entirely with an estimated $200K sold.

  • 18 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q1 2022, down from 20 in Q4 2021.
  • Funds reported $389K of Revelation Biosciences Warrant stock for Q1 2022, down 84% quarter-over-quarter.
  • 3 funds opened new Revelation Biosciences Warrant positions in Q1 2022 and 5 closed out, a net change of -2 holders.
  • The largest Revelation Biosciences Warrant buyer in Q1 2022 was Walleye Capital, an estimated $23.1K added.
  • The largest Revelation Biosciences Warrant seller in Q1 2022 was CVI Holdings, an estimated $200K sold.

Based on aggregated 13F filings for Q1 2022.